Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
3,123,407
-
Share change
-
-2,346,238
-
Total reported value
-
$33,528,000
-
Price per share
-
$10.75
-
Number of holders
-
16
-
Value change
-
-$24,757,282
-
Number of buys
-
4
-
Number of sells
-
15
Institutional Holders of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) as of Q2 2020
As of 30 Jun 2020,
REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,123,407 shares.
The largest 10 holders included
Hudson Bay Capital Management LP, MIZUHO SECURITIES USA LLC, Polar Asset Management Partners Inc., Periscope Capital Inc., GLAZER CAPITAL, LLC, BERKLEY W R CORP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, GOLDMAN SACHS GROUP INC, GABELLI & Co INVESTMENT ADVISERS, INC., and GABELLI FUNDS LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.